You are here: Industry Insights > AiVita Biomedical

News List

AIVITA Biomedical Closes $25 Million Financing Round prnewswire
December 30, 2020
AIVITA Biomedical, Inc., a private biotechnology company developing personalized vaccines for the treatment of cancer and prevention of COVID-19, has closed its Series B-2 financing round for up to $25 million. Financing was provided by several life ...
AIVITA Biomedical's Glioblastoma Trial Shows Improved Progression Free Survival americanpharmaceuticalreview
December 02, 2020
AIVITA Biomedical announced data from its multi-center Phase 2 clinical trial of its personalized cancer vaccine, AV-GBM-1, in patients with newly diagnosed glioblastoma (GBM).
AIVITA Biomedical Completes Treatment of Patients in Glioblastoma Immunotherapy Trial americanpharmaceuticalreview
November 11, 2020
AIVITA Biomedical announced treatment has been completed for all 57 patients in the Phase 2 clinical trial of AV-GBM-1 in patients with glioblastoma.
AIVITA Biomedical, Guthy-Renker collaborate for ROOT of SKIN™ biospectrumasia
April 04, 2019
AIVITA Biomedical, Inc., a biotechnology company specializing in innovative stem cell applications has entered into a partnership agreement with GRS……
AIVITA Biomedical Receives IND Clearance for Phase 1B Melanoma Trial americanpharmaceuticalreview
January 17, 2019
AIVITA Biomedical announced the U.S. Food and Drug Administration (FDA) has cleared its Investigational New Drug (IND) application for a Phase 1B clinical trial investigating the Company's ROOT OF CANCER technology in .....